ICVTS Click here to goto Smart Canula website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Interact CardioVasc Thorac Surg 2009;9:685-687. doi:10.1510/icvts.2009.208587
© 2009 European Association of Cardio-Thoracic Surgery

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Nicholas Charokopos
Polychronis Antonitsis
Christophoros Foroulis
Christos Papakonstantinou
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Charokopos, N.
Right arrow Articles by Papakonstantinou, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Charokopos, N.
Right arrow Articles by Papakonstantinou, C.

Negative results - Valves

Acute mechanical prosthetic valve thrombosis after initiating oral anticoagulation therapy. Is bridging anticoagulation with heparin required?

Nicholas Charokopos, Polychronis Antonitsis*, Panagiotis Artemiou, Efthymia Rouska, Christophoros Foroulis and Christos Papakonstantinou

Department of Thoracic and Cardiovascular Surgery, AHEPA University Hospital, Thessaloniki, Greece

*Corresponding author. Sakellaridi 25, 542 48 Thessaloniki, Greece. Tel.: +30 2310329729; fax: +30 2310329729.

E-mail address: antonits{at}otenet.gr (P. Antonitsis).

Prosthetic valve thrombosis (PVT) represents a serious and potentially lethal complication. It can be attributed more frequently to inadequate anticoagulant therapy. We present a case of acute aortic mechanical valve thrombosis six months after implantation. The patient discontinued oral anticoagulation after being discharged following the primary operation. Two days after reinitiating warfarin as an outpatient, he developed acute valve thrombosis presenting with symptoms and signs of cardiac failure. He was managed with intravenous thrombolysis with a recombinant plasminogen activator which resulted in immediate resolution of thrombus and clinical improvement. A paradox procoagulant effect of warfarin is evident on the first one or two days after initiation of therapy. A ‘bridging’ protocol with unfractionated or low molecular weight heparin (LMWH) should be considered, according to recently published guidelines, until warfarin reaches therapeutic levels and exerts an antithrombotic effect.

Key Words: Aortic valve; Mechanical valve; Anticoagulation; Thrombosis; Embolism







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 European Association for Cardio-thoracic Surgery